CCS Supplies Frozen Cells from EMD Millipore’s Cell Line Panel
CCS Cell Culture Service has signed a general license agreement with Millipore Corporation (EMD Millipore - a division of Merck KGaA, Darmstadt, Germany) that allows CCS to create bulk cell amounts from over 250 of EMD Millipore’s assay cell lines, enhancing customers’ drug discovery and high throughput functional screening capabilities.
With this agreement, CCS’s highly flexible service, which meets customers’ scale-up needs, becomes available for EMD Millipore's well-proven assay cell lines. EMD Millipore owns more than 180 GPCR-expressing cell lines (ChemiScreen™, ChemiBrite™ lines) and 60 ion channel-expressing cell lines (PrecisION® lines). From these, CCS can produce custom assay-ready frozen cells or membranes and may even use the cells as a host for transient bulk transfections....
29.12.11
InSphero and Cell Culture Service enter partnership
The biotechnology companies InSphero AG (Zurich, Switzerland) and Cell Culture Service GmbH (Hamburg, Germany) signed a commercial cooperation agreement today. The partnership fosters the implementation of 3D cell‐culture technologies in pharmaceutical development and both companies will join forces in customer projects to deliver next‐generation, organoytpic cell‐based models for compound de‐risking....
03.05.11
CCS Cell Culture Service Celebrates its 10th Anniversary
CCS Cell Culture Service GmbH, which was founded in early 2000 by the Hamburg scientist Dr. Oliver Klotzsche and his three partners, was originally dedicated to provide all kinds of cell culture related services. Within the last decade the company has advanced to one of the leading suppliers of cells and cell based reagents for pharmaceutical industries. Meanwhile CCS has 20 employees. Last year CCS launched its subsidiary at the east coast of the USA and has thereby opened a new chapter in the book of its success.
21.07.10
Transient Bulk Transfection by Flow Electroporation CCS Launches New Custom Service
CCS Cell Culture Service has established a new technology which is now offered as a custom service to clients within drug discovery industries. By using the MaxCyte® STX™ Scalable Transfection System CCS is able to transfect batches of up to 10 billion cells in less than 30 minutes. Cell lines, primary cells and stem cells are reproducibly and efficiently transfected while maintaining the integrity of the cells for subsequent assays. As a result, bulk quantities of assay-ready frozen instant cells which are transiently expressing targets of interest can now be rapidly prepared.
07.06.10
CCS announces the opening of their advanced cell culture laboratory in Princeton, New Jersey
CCS Cell Culture Service, an international supplier of custom generated recombinant cell lines, and custom frozen cells and membranes is very pleased to announce the opening of its Princeton, New Jersey laboratory and office space.
15.03.10
CCS has Recertified its Quality Management System
CCS Cell Culture Service's Quality Management System has been recertified according to ISO 9001:2008. During the recent years CCS has steadily expanded and improved its administrative and manufacturing procedures. After the initial certification in 2003 the quality management system has now.....
07.10.09

